Study finds no cases of blood clot in AstraZeneca COVID-19 vaccine
A new trial of the AstraZeneca COVID-19 vaccine by Chilean researchers has found no cases of blood clots. According to a report published on Friday by Reuters, the trial which studied 2,200 participants finds no instance of blood clots. According to the leader of the research group, who is from the University of Chile, Dr. Maria Elena Santolaya, the trial findings show the possibility of a blood clot is very minimal from the vaccination. Santolaya disclosed that his team studied people of all ages, with 20 percent of them over 60 years old. “In no age group, among women or men, did we have any blood clotting of any nature,” she said. Santolaya also cited interim results of AstraZeneca’s vaccine trials among 34,000 people in Peru, Chile, and the United States that showed it was 76 percent effective against symptomatic COVID-19, 100 percent effective against serious or critical COVID-19, and 85 percent effective against symptomatic COVID-19 among people over 65. She stated that data – ga